hematology
- India
Transasia Bio-Medicals Ltd. supports COVID-relief efforts in Sikkim by providing critical equipment
Transasia Bio-Medicals Ltd., India’s Leading IVD player for whom India comes first, has been actively supporting various state governments in…
Read More » - India
Transasia donates over 5 lakh tablets worth more than Rs. 50 lakhs for COVID-19 treatment to various NGOs, Government and Mission Hospitals
Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company, has donated over 5 lakh tablets worth more than Rs. 50 lakhs…
Read More » - Business
Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio
Osaka, Japan & Brisbane, Calif., United States: Acquisition expands Takeda’s immuno-oncology portfolio with two development candidates and Maverick’s conditionally active…
Read More » - Business
Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements
Osaka, Japan: − Seven Year Data Reinforce Long-term Efficacy and Safety Review of ADVATE (Antihemophilic Factor [Recombinant]) − Abstracts Support…
Read More » -
Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
Read More » - United States
Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index
Osaka, Japan & Cambridge, Mass., United States: Company Ranked Sixth Overall and Leads the Pharmaceutical Industry in Governance of Access…
Read More » - Business
Takeda to Present at The 39th Annual J.P. Morgan Healthcare Conference
Osaka, Japan & Cambridge, Mass., United States: Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”) will present virtually at the…
Read More » - Health
Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting
Osaka, Japan & Cambridge, Mass., United States: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present 22 company-sponsored…
Read More »